Search #ABSTRACT#
Dey, L.P. Reaches Settlement with State of West Virginia on Pricing Litigation
$850,000 settlement resolves all State pricing claims against Dey
Napa, CA, May 13, 2004 - Responding to today's announcement about the settlement between the State of West Virginia and Dey, L.P., John Kling, Senior Vice President of Legal Affairs at Dey, stated, "We are grateful that a satisfactory resolution has been achieved through amicable negotiation. With this relatively modest settlement of $850,000 behind us, we look forward to moving ahead, manufacturing and marketing high-quality pharmaceuticals for the people of West Virginia and the rest of the country."
Dey has consistently participated legally and ethically within National and various State reimbursement systems. Dey believes, as do many independent critics and government officials, that these reimbursement systems, in spite of their well-intentioned purposes, are seriously flawed. The Company is settling this litigation as a pragmatic solution to avoid the costs of continuing litigation and the vagaries inherent in it.
As part of the settlement, the State of West Virginia acknowledged that the settlement did not constitute an admission of fault or liability by Dey or its affiliates.
"As a manufacturer of generic drugs, Dey takes pride in its role in offering lower-cost alternatives to branded medications," continued Kling. "Generic products provide affordable high-quality pharmaceuticals to millions of consumers. By reaching this agreement, we can apply our time, energy, and resources to providing high-quality prescription drug products."
About Dey, L.P.
Dey, L.P., is a specialty pharmaceutical company focused on the development, manufacturing and marketing of prescription drug products for the treatment of respiratory diseases and respiratory-related allergies. Since 1978, patients have benefited from Dey's commitment to innovative and affordable health care solutions.The Web sites for DEY include www.dey.com, www.accuneb.com, www.curosurfusa.com, www.duoneb.com and www.epipen.com. Dey, L.P. is an affiliate of Merck KGaA, Darmstadt, Germany.
###
Media contacts:
Dey, L.P. Media Line 1-800-755-5560 ext. 8363
OR
Jennifer Paganelli, Feinstein Kean Healthcare, 212-880-5263
